Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs

Particle and Fibre Toxicology

Anja R Heckeroth¹  Rainer KA Roepke¹  Eva Zschiesche¹  Josephus Fourie²  Heike Williams¹  Christina Wengenmayer¹  Janina Taenzler¹ 

[1] MSD Animal Health Innovation GmbH, Zur Propstei, Schwabenheim, 55270, Germany;ClinVet International, Uitsigweg, Bainsvlei, Bloemfontein, 9338, Free State, South Africa

关键词: Efficacy;    Ctenocephalides felis;    Flea;    Dog;    Speed of kill;    Start to kill;    Onset of activity;    Fluralaner;    Chewable tablets;    Bravecto™;   

Others  :  1148805
DOI  :  10.1186/s13071-014-0567-6

 received in 2014-07-24, accepted in 2014-11-24,  发布年份 2014

【 摘 要 】

Background

Fluralaner (Bravecto™) is a novel systemic insecticide and acaricide that provides long persistent antiparasitic activity following a single administration at the minimum dose of 25 mg/kg body weight.

Methods

Three negative controlled, randomized studies were conducted in dogs to evaluate the start to kill (1 study) and the speed of flea kill (2 studies) of fluralaner. All dogs were infested prior to treatment with unfed adult C. felis fleas. Dogs in the treated groups were administered once orally with fluralaner at a minimum dose of 25 mg/kg body weight, while dogs in the control groups were not treated. Separate control and treatment groups were paired at each time point of flea assessment. Flea counts were performed by combing dogs at either 0.5, 1, 2, or 4 hours after fluralaner treatment to measure the start to kill. To evaluate the speed of flea kill over 12 weeks, flea counts were performed by combing dogs at either 4, 8, 12, or 24 hours after fluralaner treatment and then at 4, 8, 12, or 24 hours after each flea re-infestations performed at 4, 8, and 12 weeks following treatment.

Results

In the start to kill study, the fluralaner activity against fleas started already at 1 hour post-treatment (8% numerical efficacy). At 2 and 4 hours post-treatment, the flea reduction was significant with 36.7% and 88% efficacy, respectively.

In the speed of kill studies, the efficacy against fleas after fluralaner treatment was 80.5% at 4 hours and remained ≥ 99.4% at 8, 12 and 24 hours. After flea re-infestations in weeks 4, 8 and 12, the efficacy at 4 hours was 96.8, 91.4, and 33.5%, respectively. Efficacy at 8, 12 and 24 hours after flea re-infestations was 98.0-100% for the 12 weeks of the study. Except for 4 hours after the 12-week flea re-infestation, flea reduction was significant for all time points after flea re-infestation.

Conclusions

Single oral fluralaner administration rapidly eliminates existing flea infestations and provides excellent protection against fleas over 12 weeks following treatment.

【 授权许可】

   
2014 Taenzler et al.; licensee BioMed Central.

【 参考文献 】

• [1]Dryden MW, Rust MK: The cat flea: Biology, ecology and control. Vet Parasitol 1994, 52:1-19.
• [2]Carlotti DN, Jacobs DE: Therapy, control and prevention of flea allergy dermatitis in dogs and cats. Vet Derm 2000, 11:83-98.
• [3]Bruet V, Bourdeau PJ, Roussel A, Imparato L, Desfontis JC: Characterization of pruritus in canine atopic dermatitis, flea bite hypersensitivity and flea infestation and its role in diagnosis. Vet Dermatol 2012, 23:487-493.
• [4]Rust MK, Dryden MW: The biology, ecology, and management of the cat flea. Annu Rev Entomol 1997, 42:451-473.
• [5]Ozoe Y, Asahi M, Ozoe F, Nakahari K, Mita T: The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. Biochem Biophys Res Commun 2010, 391:744-749.
• [6]Gassel M, Wolf C, Noack S, Williams H, Ilg T: The novel isoxazoline ectoparasiticide fluralaner: Selective inhibition of arthropod γ-aminobutyric acid- and L-glutamategated chloride channels and insecticidal/acaricidal activity. Insect Biochem Mol Biol 2014, 45:111-124.
• [7][http:/ / www.ema.europa.eu/ docs/ en_GB/ document_library/ EPAR__Summary_for_the_public/ veterinary/ 002526/ WC500163861.pdf] webcite Bravecto EPAR summary for the public.European Medicines f. Agency. .
• [8]Rohdich N, Roepke RKA, Zschiesche E: A randomized, blinded controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs. Parasit Vectors 2014, 7:83. BioMed Central Full Text
• [9]Walther F, Allan MJ, Roepke RKA, Nuernberger MC: The effect of food on the pharmacokinetics of oral fluralaner in dogs. Parasit Vectors 2014, 7:84. BioMed Central Full Text
• [10]Blagburn BL, Dryden MW: Biology, treatment and control of flea and tick infestations. Vet Clin N Am 2009, 39(6):1173-1200.
• [11]Williams H, Young DR, Qureshi T, Zoller H, Heckeroth AR: Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment. Parasit Vectors 2014, 7:275. BioMed Central Full Text
• [12]Beck S, Schein E, Baldermann C, von Samson-Himmelstjerna G, Kohn B: Tick infestation and tick prophylaxis in dogs in the area of Berlin/Brandenburg-results of an questionnaire study. Berl Munch Tierartzl Wochenschr 2013, 126:69-76.
• [13]Coles TB, Dryden MW: Insecticide/acaricide resistance in fleas and ticks infesting dogs and cats. Parasit Vectors 2014, 7:8. BioMed Central Full Text